The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3,4-Dimethyl-7-oxo-2-(p-tolyl)-2,7-dihydro-6H-pyrazolo-[3,4-d]pyridazin-6-yl)-N-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propyl)butanamide ID: ALA4636954
PubChem CID: 156012529
Max Phase: Preclinical
Molecular Formula: C34H36N8O6
Molecular Weight: 652.71
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-n2nc3c(=O)n(CCCC(=O)NCCCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)nc(C)c3c2C)cc1
Standard InChI: InChI=1S/C34H36N8O6/c1-19-10-12-22(13-11-19)42-21(3)28-20(2)38-40(34(48)30(28)39-42)18-5-9-26(43)36-17-6-16-35-24-8-4-7-23-29(24)33(47)41(32(23)46)25-14-15-27(44)37-31(25)45/h4,7-8,10-13,25,35H,5-6,9,14-18H2,1-3H3,(H,36,43)(H,37,44,45)
Standard InChI Key: JEEWMQSGYNEVAR-UHFFFAOYSA-N
Molfile:
RDKit 2D
48 53 0 0 0 0 0 0 0 0999 V2000
7.2800 -6.8099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9894 -6.4013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9894 -5.5800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2800 -5.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5747 -6.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5747 -5.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7891 -5.3215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3019 -5.9904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7890 -6.6552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2800 -7.6312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2860 -4.3460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5324 -7.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4780 -5.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0716 -5.2714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2486 -5.2692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8322 -5.9829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2490 -6.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0707 -6.6947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0109 -5.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7024 -5.1735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4130 -5.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1261 -5.1776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8367 -5.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5497 -5.1818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8343 -6.4096 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2604 -5.5925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9693 -5.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6799 -5.5966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3929 -5.1901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1036 -5.6007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0964 -6.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8062 -6.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5202 -6.4270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8096 -5.1946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5155 -5.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1250 -5.0578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7932 -4.3147 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9813 -4.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4325 -3.7835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9278 -5.2347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2084 -3.6043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0338 -3.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4447 -2.9050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0421 -2.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2198 -2.1903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8002 -2.8954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4372 -4.3261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4543 -1.4840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6 4 1 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 5 2 0
1 10 1 0
4 11 2 0
9 12 1 0
8 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
3 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 35 1 0
34 30 1 0
34 35 2 0
35 36 1 0
36 37 1 0
37 38 1 0
38 34 1 0
38 39 2 0
36 40 2 0
37 41 1 0
41 42 1 0
41 46 1 0
42 43 1 0
43 44 1 0
44 45 1 0
45 46 1 0
42 47 2 0
44 48 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 652.71Molecular Weight (Monoisotopic): 652.2758AlogP: 2.31#Rotatable Bonds: 11Polar Surface Area: 177.39Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.59CX Basic pKa: 2.11CX LogP: 1.69CX LogD: 1.69Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.16Np Likeness Score: -1.31
References 1. Cheng J, Li Y, Wang X, Dong G, Sheng C.. (2020) Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer., 63 (14): [PMID:32603594 ] [10.1021/acs.jmedchem.0c00929 ] 2. Zimmermann, Gunther G and 8 more authors. 2014-06-26 Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site. [PMID:24884780 ] 3. Cheng, Junfei; Li, Yu; Wang, Xu; Dong, Guoqiang and Sheng, Chunquan. 2020-07-23 Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer. [PMID:32603594 ]